Vasculitis and Giant Cell Arteritis

Top Story

Few rheumatic adverse events from immune checkpoint inhibitors require discontinuation

November 15, 2018
Meeting NewsGuidelinesPerspective

Draft criteria for large-vessel vasculitis support key role for imaging

November 13, 2018
CHICAGO — Advanced vascular imaging is expected to play an increasingly important role in the diagnosis and management of large-vessel vasculitis, according to a…
Meeting News

Apremilast effective for oral ulcers in Behçet's Syndrome

November 12, 2018
CHICAGO — Apremilast is effective for the treatment of oral ulcers, and generally well tolerated, among patients with Behçet’s Syndrome, according to data…
Blog

Recapping the ACR Review Course: What You May Have Missed This Year

November 8, 2018
I always look forward to the ACR yearly review course for an engaging way to get updates on various topics in the field of rheumatology. It’s also a way to…
More Headlines »
CME ABIM MOC

Ace the Case: A 72-Year-Old Woman with Several Weeks of Pain and Stiffness in Her Shoulders, Neck, and Pelvic Region

There is no commercial support for this activity.

This “Ace the Case” study will explore the diagnosis and management of a 72-year-old female who complains of several…
More »
Video
Meeting News Coverage

VIDEO: A look at tocilizumab for treatment of giant cell arteritis

July 7, 2016
More »
CME

Multidisciplinary Perspectives in Giant Cell Arteritis: A Team-based Approach for Improved Quality of Care

This activity is supported by an educational grant from Genentech, Inc.

Giant cell arteritis (GCA) is the most common form of medium- and large-vessel vasculitis. If left untreated, patients…
More »